News from Our Parnters

Partner News: Prelude Therapeutics presents preclinical data for KAT6A degrader programMay 6, 2026

Prelude Therapeutics, a resident of the Innovation Space, announced the presentation of new preclinical data for its lead development candidate, PRT13722, at the American Association for Cancer Research (AACR) Annual […]

Partner News: Prelude Therapeutics secures $90 million through underwritten offeringMay 5, 2026

In an article featured in Prelude Therapeutics investor news, Prelude Therapeutics announced the pricing of a $90 million underwritten offering to support the continued advancement of its precision oncology pipeline. […]

Partner News: Novartis to Acquire Synnovation Therapeutics’ PI3Kα Inhibitor ProgramMarch 20, 2026

In an article featured in Business Wire, Synnovation Therapeutics announced a definitive agreement for Novartis to acquire Pikavation Therapeutics, a wholly owned subsidiary of Synnovation, along with its portfolio of […]

Technical.ly: Synnovation Therapeutics announces its plans to double down on Delaware February 20, 2025

Synnovation Therapeutics expands at Innovation Space, advancing precision oncology and Delaware’s life science ecosystem January 29, 2025

In an article from Choose Delaware the Innovation Space is featured as a catalyst for breakthrough science and startup growth, as Synnovation Therapeutics has announced plans to significantly expand its […]

Delaware Bio: Innovation Space’s new grant helps start-ups take next step December 2, 2024

Delaware Roundup: Quick Reads (11/29)November 29, 2024

Delaware Live: AirJoule, water harvesting company, picks Del. for main office and more July 23, 2024

Technical.ly: 5 Delaware startups fighting the climate crisis July 17, 2024